Table II.

The methylation rate of CpG islands in the Wnt5a promoter in AML patients (A-C) and normal controls (D-F).

	Methylation (%)
Sample ID	Pos. 1	Pos. 2	Pos. 3	Pos. 4	Pos. 5	Pos. 6	No. of included CpGs	Mean (%)
A	45.34	51.39	49.64	82.35	71.12	81	6	63.47
B	56.97	34.83	42.72	80.22	69.23	64.79	6	58.13
C	71.64	76.2	73.98	71.66	70.77	72.6	6	72.81
D	5.47	5.04	0	0	0	5.3	6	2.64
E	4.55	5.54	4.34	3.85	5.26	6.15	6	4.95
F	3.79	4.07	3.22	4.52	5.09	7.23	6	4.65

AML, acute myeloid leukemia.